Greenwich Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-4,870
Closed -$432K – 225
2021
Q1
$432K Buy
+4,870
New +$483K 0.03% 145

Other funds holding ARKG

Greenwich Wealth Management's ARKG Position: Q2 2021 in Review

Greenwich Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 4,870 shares — an estimated $432K sold.

Greenwich Wealth Management first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $432K in Q1 2021. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Greenwich Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Greenwich Wealth Management sold 4,870 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $432K.
  • Greenwich Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Greenwich Wealth Management's ARK Genomic Revolution ETF position peaked at $432K in Q1 2021.
  • 514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Greenwich Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2021.